Bloomberg Audio Studios, podcasts, radio news, The.
Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.
Let's take a look at some of the stocks on the move today in Europe. I'm Lizzie Bernin in London with Stephen Carroll in Brussels, and we're joined by Bloomberg reporter Chloe Melly.
Chloe, let's start with Ryanair.
I spoke to the CFO earlier this morning and things were looking up for them then for the share price now not exactly jetting away.
No, absolutely, Ryana raised guidance for passonage growth and fair so that explains why the cf IT was probably quite happy this morning, and that was thanks to a really strong travel demand and also a good progress being made on Boeing deliveries. So that was an area of quite a lot of frustration over the last year, but that's
now getting a lot better. But Chaz did fall little, as you mentioned this morning, because analysts are seeing this outlook is perhaps quite cautious, quite concerned, avative, but they did say that this is not really a massive course for concern and even with a little bit of weakness in the share price.
Ryana is still way ahead.
Of low cost rivals like Wizz and easy Jets, so it's on it's on a pretty good standing even despite this.
This is a little bit of weakness this morning.
And also the results just come a few days after the spat between.
The CEO and Michael O'Leary and Elon.
Musk which was over the starling Wi Fi service from SpaceX and Ryan I said that it helped bookings thanks to a little bit more publicity, and the CFO today reiterated that the airline does not want, does not want what that Wi Fi service because of the cost of installation being quite high and also passengers not wanting to pay for Wi Fi on those really short flights, which I completely agree with you.
Colleen must a big idiot when I was speaking to him. It helped the bookings.
We're going to turn now to the some stocks in France a crisis an infant formula following dun Own's recall of some infant formula batches.
We've got several shares under pressure there. Yeah, so dan On, but also Nestle and Group Blackedlist.
All of those companies are caught in the middle of this infant formula crisis, and this actually.
Started with Nesley.
But now we have those other two down On and Group lacked lists pulling products but that are potentially contaminated with a toxin, and that is related to an international supply, and that's affecting a lot of different markets of different countries.
And don On is particularly under pressure today because it expanded a recall of some of those batches infant formula batches to more European markets lit on Friday, and it said that it was due to changing standards from regulators, and it reiterated that its products were safe and that the recall was a completely precautionary measure.
But we are seeing those shares.
Are down this morning, and a lot of those other stocks as well, and wreck It was also down. Group Blacklist was also down, and Nestley is not down as much, but it's actually the company that is the worst affected.
It had to pour products from in shells from more than sixty countries and an unalyst at Barclay said that the cost Denon could be up to one hundred million euros, but that the financial damage for Nesla could actually be ten times higher and so Obviously, this quite a lot of questions about control standards, quality standards, investments in production sites, and so this is going to be a story to follow as those companies also report in the next few weeks.
Okay and Corey, I hate to leave things on a sour note, but it looks like we could have another London Stock Exchange exit, some pee names swirling around Spire Healthcare. How's the market reacting.
Well, the malk is reacting very positively for Spire Healthcare. Shares actually started this morning because of that potential private equity deal and the talks are still preliminary.
They are still potentially other suitors.
But this is actually sometime in the making for Spire Healthcare because back in September it confirmed it was working with Rothschild and exploring some options, including a potential sale. And right now the bid comes at a time of quite a weakness for Spuire Healthcare. It had a massive profit warning back in December and that had really sent the shares plunging. But if the deal happens, it might be great for shareholders, but as you say, it might
be another big loss for the London Stock Exchange. Within that same sect of kind of healthcare real estate. We had Asura last year which was bought by by Primary Health Properties, and that was after quite a long takeover battle that involved another private equity firm, KKI if we remember. So we have that private equity swirling in that potential another big loss for the London Stock Exchange, so that'll be something to look out for as well.
The Stock Movers report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.